- Home
- IDN vs MDCX Comparison
IDN vs MDCX Comparison
Compare IDN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- MDCX
- Stock Information
- Founded
- IDN 1994
- MDCX 2008
- Country
- IDN United States
- MDCX Canada
- Employees
- IDN N/A
- MDCX N/A
- Industry
- IDN Computer Software: Prepackaged Software
- MDCX
- Sector
- IDN Technology
- MDCX
- Exchange
- IDN Nasdaq
- MDCX Nasdaq
- Market Cap
- IDN 59.5M
- MDCX 48.4M
- IPO Year
- IDN 1999
- MDCX N/A
- Fundamental
- Price
- IDN $5.09
- MDCX $2.55
- Analyst Decision
- IDN Strong Buy
- MDCX Strong Buy
- Analyst Count
- IDN 3
- MDCX 2
- Target Price
- IDN $5.83
- MDCX $23.50
- AVG Volume (30 Days)
- IDN 526.6K
- MDCX 383.9K
- Earning Date
- IDN 05-13-2025
- MDCX 05-12-2025
- Dividend Yield
- IDN N/A
- MDCX N/A
- EPS Growth
- IDN N/A
- MDCX N/A
- EPS
- IDN N/A
- MDCX N/A
- Revenue
- IDN $20,211,000.00
- MDCX N/A
- Revenue This Year
- IDN $8.56
- MDCX N/A
- Revenue Next Year
- IDN $9.64
- MDCX N/A
- P/E Ratio
- IDN N/A
- MDCX N/A
- Revenue Growth
- IDN 4.55
- MDCX N/A
- 52 Week Low
- IDN $1.92
- MDCX $1.80
- 52 Week High
- IDN $5.46
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- IDN 76.01
- MDCX N/A
- Support Level
- IDN $3.67
- MDCX N/A
- Resistance Level
- IDN $5.46
- MDCX N/A
- Average True Range (ATR)
- IDN 0.51
- MDCX 0.00
- MACD
- IDN 0.18
- MDCX 0.00
- Stochastic Oscillator
- IDN 86.25
- MDCX 0.00
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.